外付け排尿管理製品のグローバル市場2022-2031:男性、女性

■ 英語タイトル:External Urine Management Products Market, by Gender (Male and Female), Product Type (Urine Collection Catheters & Bags and Pads & Diapers), Product Category (Disposable and Non-Disposable), Distribution Channel (Online Channel and Offline Channel), and End User (Hospitals, Diagnostic Laboratories & Clinics, and Homecare Settings): Global Opportunity Analysis and Industry Forecast 2022–2031

調査会社Research Dive社が発行したリサーチレポート(データ管理コード:RDV23MA020)■ 発行会社/調査会社:Research Dive
■ 商品コード:RDV23MA020
■ 発行日:2022年12月27日
■ 調査対象地域:グローバル
■ 産業分野:生命科学
■ ページ数:225
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD5,700 ⇒換算¥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算¥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算¥1,626,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[外付け排尿管理製品のグローバル市場2022-2031:男性、女性]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Research Dive社によると、世界の外付け排尿管理製品市場規模は2021年15,940百万ドルから2031年には31,929.3百万ドルまで、年平均7.4%の成長率を表すと見込まれます。本レポートでは、外付け排尿管理製品の世界市場を調査・分析し、調査手法、調査範囲、エグゼクティブサマリー、市場概要、性別(男性、女性)分析、製品種類別(尿採取カテーテル&バッグ、パッド&おむつ)分析、製品カテゴリ別(使い捨て、非使い捨て)分析、流通チャネル別(オンラインチャネル、オフラインチャネル)分析、エンドユーザー別(病院、診断研究所&クリニック、在宅医療)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、競争状況など、以下のようにまとめました。本書の参入企業情報としては、Teleflex, Inc., Tilla Care, Inc., Consure Medical, Hollister Inc., Men’s Liberty (BioDerm), Boehringer Laboratories, LLC, Hollister, Inc., Coloplast Corp., Sterimed Group, and Cardinal Health.などがあります。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界の外付け排尿管理製品市場規模:性別
- 男性における市場規模
- 女性における市場規模
・世界の外付け排尿管理製品市場規模:製品種類別
- 尿採取カテーテル&バッグの市場規模
- パッド&おむつの市場規模
・世界の外付け排尿管理製品市場規模:製品カテゴリ別
- 使い捨て製品の市場規模
- 非使い捨て製品の市場規模
・世界の外付け排尿管理製品市場規模:流通チャネル別
- オンラインチャネルの市場規模
- オフラインチャネルの市場規模
・世界の外付け排尿管理製品市場規模:地域別
- 北米の外付け排尿管理製品市場規模
- ヨーロッパの外付け排尿管理製品市場規模
- アジア太平洋の外付け排尿管理製品市場規模
- 中南米の外付け排尿管理製品市場規模
- 中東/アフリカの外付け排尿管理製品市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global external urine management products market is anticipated to generate revenue of $31,929.3 million by 2031, increasing from $15,940 million in 2021, at a CAGR of 7.4%.

COVID-19 Impact on the Global External Urine Management Products Market:
The COVID-19 pandemic caused several concerns, resulting in serious economic losses as various businesses all over the world came to a halt. However, it had a positive impact on the healthcare industry. The COVID-19 pandemic had a significant influence on the manufacturing and supply chain & logistics businesses, as well as the healthcare industry. The application of social distancing standards and the alteration of conventional operating protocols have hampered the day-to-day functioning of various healthcare facilities worldwide. The external urine management products market is expanding as a consequence of significant efforts by healthcare providers and market participants. The global market is being pushed by the increasing prevalence of urinary incontinence and an older population that has difficulty passing urine regularly. Manufacturers in the global external urine management products market are focusing on advancements and increasing urinary catheter production.

External Urine Management Products Market Analysis:
External urine management devices are used by patients who are unable to walk from one area to another due to urinary retention, incontinence, or urological or gynecological surgeries. The prevalence of urological illnesses such as urinary strictures, benign prostatic hyperplasia, and several other indications is increasing the demand for external urine management products across the globe. In situations where an individual waiting for treatment to take effect refuses to seek a cure or cannot be fully cured, external urine management devices play a significant role in improving the quality of life and eliminating the stigma associated with incontinence. These external urine management products are used to drain urine from bladders in people who are unable to do so properly. These factors are anticipated to boost the external urine management products market growth.
A significant improvement in patient care has been achieved with the advent of implantable medical devices, including urinary catheters, which are used in almost 25% to 30% of hospitalized patients.
Patients with catheters in their bladders may experience cramp-like contractions. Urinary catheters have poor ultraviolet and chemical resistance, which exhibits in the form of an allergic reaction in a patient and may lead to the formation of biofilms. These catheters are only intended to be used for a short period of time since external catheters are more prone to causing urinary tract infections. All these factors are anticipated to restrain the external urine management products’ market demand during the forecast period.

Patient care has improved significantly since the introduction of indwelling medical devices. Among them, between 15 and 25 percent of hospitalized patients use urinary catheters. External urine management is used to manage urine discharge, urinary retention, and urinary incontinence in both male and female patients who have had surgery or have mobility issues. External urine management products are made from a variety of materials, including polyvinyl chloride (PVC), latex rubber, polyurethane, and silicone, due to their malleability. High tensile strength, pliability, and resistance to corrosion and chemicals are desirable features of materials used in the manufacture of urine management products. Latex is widely used in urine management products, but it has been discovered that it has low chemical and ultraviolet resistance, causes allergic reactions in patients, has a rough surface, and can contribute to the production of biofilms.

An antimicrobial chemical that is coated or incorporated into such materials and which may be bactericidal, bacteriostatic, or function as an antifouling agent can stop the growth of pathogenic bacteria in external urine management products to prevent biofilms caused by them. Some antimicrobial medicines have been studied and validated through clinical studies, while others are currently in the clinical trial and development stages. The most often used antimicrobial catheters are silver or antibiotic-coated catheters, which have been extensively investigated in clinical trials and are shown to minimize CAUTIs. All these aspects are predicted to boost the external urine management products market in the coming years.
On the basis of gender, the female segment accounted for a dominating market share in 2021. Urinary incontinence is more common in females due to anatomical outlet obstruction and bladder dysfunction, which are linked to neurological disease, infection, medicines, and discomfort.
On the basis of product type, the pads & diapers segment accounted for a dominating market share in 2021, as pads and diapers are safe & hygienic and provide excellent incontinence management.

On the basis of product category, the disposable segment had a dominating market share in 2021due to the rise in prevalence of renal disorders and nephrological injuries, technological developments in the materials used for disposable goods and catheters and increase in awareness of individualized care and hygiene. These factors are driving the market expansion.
On the basis of distribution channel, the offline segment had a dominating market share in 2021 because it is the first point of contact for customers and companies to supply and sell products to customers.
On the basis of end user, the hospitals segment accounted for a dominating market share in 2021. The rising frequency of end-stage renal diseases and the increase in the number of surgical procedures performed are two key factors driving the segment growth.
On the basis of region, the North America market accounted for a dominating market share in 2021 due to the rise in the occurrence of particular diseases such as urinary tract infection (UI), bladder obstruction, urine retention, and bladder cancer.
The companies involved in the global external urine management products market include Teleflex, Inc., Tilla Care, Inc., Consure Medical, Hollister Inc., Men’s Liberty (BioDerm), Boehringer Laboratories, LLC, Hollister, Inc., Coloplast Corp., Sterimed Group, and Cardinal Health.

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global external urine management products market

3.Executive Summary

4.Market Overview

4.1.Introduction

4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Legal
4.6.6.Environmental

4.7.Impact of COVID-19 on external urine management products market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.External Urine Management Products Market Analysis, by Gender

5.1.Overview

5.2.Male

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031

5.3.Female

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031

5.4.Research Dive Exclusive Insights

5.4.1.Market attractiveness

5.4.2.Competition heatmap

6.External Urine Management Products Market Analysis, by Product Type

6.1.Overview

6.2.Urine Collection Catheters and Bags

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region, 2021-2031
6.2.3.Market share analysis, by country, 2021-2031

6.3.Pads and Diapers

6.3.1.Definition, key trends, growth factors, and opportunities
6.3.2.Market size analysis, by region, 2021-2031
6.3.3.Market share analysis, by country, 2021-2031

6.4.Research Dive Exclusive Insights

6.4.1.Market attractiveness
6.4.2.Competition heatmap

7.External Urine Management Products Market Analysis, by Product Category

7.1.Overview

7.2.Disposable

7.2.1.Definition, key trends, growth factors, and opportunities
7.2.2.Market size analysis, by region, 2021-2031
7.2.3.Market share analysis, by country, 2021-2031

7.3.Non- Disposable

7.3.1.Definition, key trends, growth factors, and opportunities
7.3.2.Market size analysis, by region, 2021-2031
7.3.3.Market share analysis, by country, 2021-2031

7.4.Research Dive Exclusive Insights

7.4.1.Market attractiveness
7.4.2.Competition heatmap

8.External Urine Management Products Market Analysis, by Distribution Channel

8.1.Overview

8.2.Online Channel

8.2.1.Definition, key trends, growth factors, and opportunities
8.2.2.Market size analysis, by region, 2021-2031
8.2.3.Market share analysis, by country, 2021-2031

8.3.Offline channel

8.3.1.Definition, key trends, growth factors, and opportunities
8.3.2.Market size analysis, by region, 2021-2031
8.3.3.Market share analysis, by country, 2021-2031

8.4.Research Dive Exclusive Insights

8.4.1.Market attractiveness
8.4.2.Competition heatmap

9.External Urine Management Products Market Analysis, by End User

9.1.Overview

9.2.Hospitals

9.2.1.Definition, key trends, growth factors, and opportunities
9.2.2.Market size analysis, by region, 2021-2031
9.2.3.Market share analysis, by country, 2021-2031

9.3.Diagnostic Laboratories and Clinics

9.3.1.Definition, key trends, growth factors, and opportunities
9.3.2.Market size analysis, by region, 2021-2031
9.3.3.Market share analysis, by country, 2021-2031

9.4.Homecare Settings

9.4.1.Definition, key trends, growth factors, and opportunities
9.4.2.Market size analysis, by region, 2021-2031
9.4.3.Market share analysis, by country, 2021-2031

9.5.Research Dive Exclusive Insights

9.5.1.Market attractiveness
9.5.2.Competition heatmap

10.External Urine Management Products Market, by Region

10.1.North America

10.1.1.U.S.

10.1.1.1.Market size analysis, by Gender, 2021-2031
10.1.1.2.Market size analysis, by Product Type, 2021-2031
10.1.1.3.Market size analysis, by Product Category,2021-2031
10.1.1.4.Market size analysis, by Distribution channel,2021-2031
10.1.1.5.Market size analysis, by End User

10.1.2.Canada

10.1.2.1.Market size analysis, by Gender,2021-2031
10.1.2.2.Market size analysis, by Product Type,2021-2031
10.1.2.3.Market size analysis, by Product Category,2021-2031
10.1.2.4.Market size analysis, by Distribution channel,2021-2031
10.1.2.5.Market size analysis, by End User,2021-2031

10.1.3.Mexico

10.1.3.1.Market size analysis, by Gender,2021-2031
10.1.3.2.Market size analysis, by Product Type,2021-2031
10.1.3.3.Market size analysis, by Product Category,2021-2031
10.1.3.4.Market size analysis, by Distribution channel,2021-2031
10.1.3.5.Market size analysis, by End User,2021-2031

10.1.4.Research Dive Exclusive Insights

10.1.4.1.Market attractiveness
10.1.4.2.Competition heatmap

10.2.Europe

10.2.1.Germany

10.2.1.1.Market size analysis, by Gender,2021-2031
10.2.1.2.Market size analysis, by Product Type,2021-2031
10.2.1.3.Market size analysis, by Product Category,2021-2031
10.2.1.4.Market size analysis, by Distribution channel,2021-2031
10.2.1.5.Market size analysis, by End User,2021-2031

10.2.2.UK

10.2.2.1.Market size analysis, by Gender,2021-2031
10.2.2.2.Market size analysis, by Product Type,2021-2031
10.2.2.3.Market size analysis, by Product Category,2021-2031
10.2.2.4.Market size analysis, by Distribution channel,2021-2031
10.2.2.5.Market size analysis, by End User,2021-2031

10.2.3.France

10.2.3.1.Market size analysis, by Gender,2021-2031
10.2.3.2.Market size analysis, by Product Type,2021-2031
10.2.3.3.Market size analysis, by Product Category,2021-2031
10.2.3.4.Market size analysis, by Distribution channel,2021-2031
10.2.3.5.Market size analysis, by End User,2021-2031

10.2.4.Spain

10.2.4.1.Market size analysis, by Gender,2021-2031
10.2.4.2.Market size analysis, by Product Type,2021-2031
10.2.4.3.Market size analysis, by Product Category,2021-2031
10.2.4.4.Market size analysis, by Distribution channel,2021-2031
10.2.4.5.Market size analysis, by End User,2021-2031

10.2.5.Italy

10.2.5.1.Market size analysis, by Gender,2021-2031
10.2.5.2.Market size analysis, by Product Type,2021-2031
10.2.5.3.Market size analysis, by Product Category,2021-2031
10.2.5.4.Market size analysis, by Distribution channel,2021-2031
10.2.5.5.Market size analysis, by End User,2021-2031

10.2.6.Rest of Europe

10.2.6.1.Market size analysis, by Gender,2021-2031
10.2.6.2.Market size analysis, by Product Type,2021-2031
10.2.6.3.Market size analysis, by Product Category,2021-2031
10.2.6.4.Market size analysis, by Distribution channel,2021-2031
10.2.6.5.Market size analysis, by End User,2021-2031

10.2.7.Research Dive Exclusive Insights

10.2.7.1.Market attractiveness
10.2.7.2.Competition heatmap

10.3.Asia Pacific

10.3.1.China

10.3.1.1.Market size analysis, by Gender,2021-2031
10.3.1.2.Market size analysis, by Product Type,2021-2031
10.3.1.3.Market size analysis, by Product Category,2021-2031
10.3.1.4.Market size analysis, by Distribution channel,2021-2031
10.3.1.5.Market size analysis, by End User,2021-2031

10.3.2.Japan

10.3.2.1.Market size analysis, by Gender,2021-2031
10.3.2.2.Market size analysis, by Product Type,2021-2031
10.3.2.3.Market size analysis, by Product Category,2021-2031
10.3.2.4.Market size analysis, by Distribution channel,2021-2031
10.3.2.5.Market size analysis, by End User,2021-2031

10.3.3.India

10.3.3.1.Market size analysis, by Gender,2021-2031
10.3.3.2.Market size analysis, by Product Type,2021-2031
10.3.3.3.Market size analysis, by Product Category,2021-2031
10.3.3.4.Market size analysis, by Distribution channel,2021-2031
10.3.3.5.Market size analysis, by End User,2021-2031

10.3.4.Australia

10.3.4.1.Market size analysis, by Gender,2021-2031
10.3.4.2.Market size analysis, by Product Type,2021-2031
10.3.4.3.Market size analysis, by Product Category,2021-2031
10.3.4.4.Market size analysis, by Distribution channel,2021-2031
10.3.4.5.Market size analysis, by End User,2021-2031

10.3.5.South Korea

10.3.5.1.Market size analysis, by Gender,2021-2031
10.3.5.2.Market size analysis, by Product Type,2021-2031
10.3.5.3.Market size analysis, by Product Category,2021-2031
10.3.5.4.Market size analysis, by Distribution channel,2021-2031
10.3.5.5.Market size analysis, by End User,2021-2031

10.3.6.Rest of Asia Pacific

10.3.6.1.Market size analysis, by Gender,2021-2031
10.3.6.2.Market size analysis, by Product Type,2021-2031
10.3.6.3.Market size analysis, by Product Category,2021-2031
10.3.6.4.Market size analysis, by Distribution channel,2021-2031
10.3.6.5.Market size analysis, by End User,2021-2031

10.3.7.Research Dive Exclusive Insights

10.3.7.1.Market attractiveness
10.3.7.2.Competition heatmap

10.4.LAMEA

10.4.1.Brazil

10.4.1.1.Market size analysis, by Gender,2021-2031
10.4.1.2.Market size analysis, by Product Type,2021-2031
10.4.1.3.Market size analysis, by Product Category,2021-2031
10.4.1.4.Market size analysis, by Distribution channel,2021-2031
10.4.1.5.Market size analysis, by End User,2021-2031

10.4.2.Saudi Arabia

10.4.2.1.Market size analysis, by Gender,2021-2031
10.4.2.2.Market size analysis, by Product Type,2021-2031
10.4.2.3.Market size analysis, by Product Category,2021-2031
10.4.2.4.Market size analysis, by Distribution channel,2021-2031
10.4.2.5.Market size analysis, by End User,2021-2031

10.4.3.UAE

10.4.3.1.Market size analysis, by Gender,2021-2031
10.4.3.2.Market size analysis, by Product Type,2021-2031
10.4.3.3.Market size analysis, by Product Category,2021-2031
10.4.3.4.Market size analysis, by Distribution channel,2021-2031
10.4.3.5.Market size analysis, by End User,2021-2031

10.4.4.South Africa

10.4.4.1.Market size analysis, by Gender,2021-2031
10.4.4.2.Market size analysis, by Product Type,2021-2031
10.4.4.3.Market size analysis, by Product Category,2021-2031
10.4.4.4.Market size analysis, by Distribution channel,2021-2031
10.4.4.5.Market size analysis, by End User,2021-2031

10.4.5.Rest of LAMEA

10.4.5.1.Market size analysis, by Gender,2021-2031
10.4.5.2.Market size analysis, by Product Type,2021-2031
10.4.5.3.Market size analysis, by Product Category,2021-2031
10.4.5.4.Market size analysis, by Distribution channel,2021-2031
10.4.5.5.Market size analysis, by End User,2021-2031

10.4.6.Research Dive Exclusive Insights

10.4.6.1.Market attractiveness
10.4.6.2.Competition heatmap

11.Competitive Landscape

11.1.Top winning strategies, 2021

11.1.1.By strategy
11.1.2.By year
11.2.Strategic overview
11.3.Market share analysis, 2021

12.Company Profiles

12.1.Teleflex Inc.

12.1.1.Overview
12.1.2.Business segments
12.1.3.Product portfolio
12.1.4.Financial performance
12.1.5.Recent developments
12.1.6.SWOT analysis
12.1.7.Research dive analyst view

12.2.Tilla Care Inc.

12.2.1.Overview
12.2.2.Business segments
12.2.3.Product portfolio
12.2.4.Financial performance
12.2.5.Recent developments
12.2.6.SWOT analysis
12.2.7.Research dive analyst view

12.3.Consure Medical

12.3.1.Overview
12.3.2.Business segments
12.3.3.Product portfolio
12.3.4.Financial performance
12.3.5.Recent developments
12.3.6.SWOT analysis
12.3.7.Research dive analyst view

12.4.Sage Products LLC (Stryker Corporation)

12.4.1.Overview
12.4.2.Business segments
12.4.3.Product portfolio
12.4.4.Financial performance
12.4.5.Recent developments
12.4.6.SWOT analysis
12.4.7.Research dive analyst view

12.5.Men’s Liberty (BioDerm)

12.5.1.Overview
12.5.2.Business segments
12.5.3.Product portfolio
12.5.4.Financial performance
12.5.5.Recent developments
12.5.6.SWOT analysis
12.5.7.Research dive analyst view

12.6.Boehringer Laboratories, LLC,

12.6.1.Overview
12.6.2.Business segments
12.6.3.Product portfolio
12.6.4.Financial performance
12.6.5.Recent developments
12.6.6.SWOT analysis
12.6.7.Research dive analyst view

12.7.Coloplast Corp.

12.7.1.Overview
12.7.2.Business segments
12.7.3.Product portfolio
12.7.4.Financial performance
12.7.5.Recent developments
12.7.6.SWOT analysis
12.7.7.Research dive analyst view

12.8.Sterimed Group

12.8.1.Overview
12.8.2.Business segments
12.8.3.Product portfolio
12.8.4.Financial performance
12.8.5.Recent developments
12.8.6.SWOT analysis
12.8.7.Research dive analyst view

12.9.Cardinal Health

12.9.1.Overview
12.9.2.Business segments
12.9.3.Product portfolio
12.9.4.Financial performance
12.9.5.Recent developments
12.9.6.SWOT analysis
12.9.7.Research dive analyst view

12.10.Hollister Inc.

12.10.1.Overview
12.10.2.Business segments
12.10.3.Product portfolio
12.10.4.Financial performance
12.10.5.Recent developments
12.10.6.SWOT analysis
12.10.7.Research dive analyst view

13.Appendix

13.1.Parent & peer market analysis
13.2.Premium insights from industry experts
13.3.Related reports



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(RDV23MA020 )"外付け排尿管理製品のグローバル市場2022-2031:男性、女性" (英文:External Urine Management Products Market, by Gender (Male and Female), Product Type (Urine Collection Catheters & Bags and Pads & Diapers), Product Category (Disposable and Non-Disposable), Distribution Channel (Online Channel and Offline Channel), and End User (Hospitals, Diagnostic Laboratories & Clinics, and Homecare Settings): Global Opportunity Analysis and Industry Forecast 2022–2031)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。